Oncocytic thyroid neoplasms: from histology to molecular biology
作者： Sule Canberk , Ana Rita Lima , Marcelo Correia , Rui Batista , Paula Soares
DOI: 10.1016/J.MPDHP.2019.02.002
关键词:
摘要: Abstract The recent update of the 4th edition World Health Organization's Classification Tumors Endocrine Organs introduced important changes in nomenclature follicular-cell thyroid tumors, namely, regarding mitochondrion-rich neoplasms (In this review, for practical purposes, words Hurthle and oncocytic are synonymous field pathology.) According to last edition, neoplasms, with follicular architecture no typical nuclei papillary carcinoma, – now included a separate group - cell neoplasms. Whenever thus categorized-while keeping variant papillary, medullary poorly differentiated carcinoma-, sort tidal phenomenon has occurred about tumors known decades. Through categorization, pathologists researchers need progress discussion etiopathogenesis (ONs). This review provides an attempt balance facts doubts by questioning based on what is tumors.
diagnostichistopathology.co.uk参考文章(77)
N. A. Samaan, Y. K. Maheshwari, S. Nader, C. S. Hill, P. N. Schultz, T. P. Haynie, R. C. Hickey, R. L. Clark, H. Goepfert, M. L. Ibanez, C. E. Litton, Impact of Therapy for Differentiated Carcinoma of the Thyroid: An Analysis of 706 Cases* The Journal of Clinical Endocrinology and Metabolism. ,vol. 56, pp. 1131- 1138 ,(1983) , 10.1210/JCEM-56-6-1131
Mithat Gönen, Richard J. Robbins, Steven M. Larson, Heiko Schöder, Henry W.D. Yeung, Daniel A. Pryma, Daniel A. Pryma, Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hürthle Cell Thyroid Cancer Patients The Journal of Nuclear Medicine. ,vol. 47, pp. 1260- 1266 ,(2006)
David S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Richard T. Kloos, Stephanie L. Lee, Susan J. Mandel, Ernest L. Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger, Steven I. Sherman, David L. Steward, R. Michael Tuttle, Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer Thyroid. ,vol. 19, pp. 1167- 1214 ,(2009) , 10.1089/THY.2009.0110
Willem E. Corver, Dina Ruano, Karin Weijers, Wietske C. E. den Hartog, Merlijn P. van Nieuwenhuizen, Noel de Miranda, Ronald van Eijk, Anneke Middeldorp, Ekaterina S. Jordanova, Jan Oosting, Ellen Kapiteijn, Guido Hovens, Jan Smit, Tom van Wezel, Hans Morreau, Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0038287
Rue-Tsuan Liu, Chia-Yi Hou, Huey-Ling You, Chao-Cheng Huang, Hock-Liew, Fong-Fu Chou, Pei-Wen Wang, Jiin-Tsuey Cheng, Selective Occurrence of ras Mutations in Benign and Malignant Thyroid Follicular Neoplasms in Taiwan Thyroid. ,vol. 14, pp. 616- 621 ,(2004) , 10.1089/1050725041692882
Jan L. Kasperbauer, Brian P. Mullan, Val J. Lowe, Ian D. Hay, Brian McIver, 18F-FDG PET of Patients with Hürthle Cell Carcinoma The Journal of Nuclear Medicine. ,vol. 44, pp. 1402- 1406 ,(2003)
Matthias S Dettmer, Aurel Perren, Holger Moch, Paul Komminoth, Yuri E Nikiforov, Marina N Nikiforova, MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. Journal of Molecular Endocrinology. ,vol. 52, pp. 181- 189 ,(2014) , 10.1530/JME-13-0266
Neil Bhattacharyya, Survival and Prognosis in Hürthle Cell Carcinoma of the Thyroid Gland Archives of Otolaryngology–Head & Neck Surgery. ,vol. 129, pp. 207- 210 ,(2003) , 10.1001/ARCHOTOL.129.2.207
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy, Patrícia Castro, Hugo Prazeres, Jorge Lima, Teresina Amaro, Cláudia Lobo, Maria João Martins, Margarida Moura, Branca Cavaco, Valeriano Leite, José Manuel Cameselle-Teijeiro, Francisco Carrilho, Manuela Carvalheiro, Valdemar Máximo, Manuel Sobrinho-Simões, Paula Soares, TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, pp. 754- 765 ,(2014) , 10.1210/JC.2013-3734
Gennaro Chiappetta, Paolo Toti, Francesco Cetta, Ada Giuliano, Francesca Pentimalli, Ida Amendola, Stefano Lazzi, Mario Monaco, Luca Mazzuchelli, Piero Tosi, Massimo Santoro, Alfredo Fusco, The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. The Journal of Clinical Endocrinology and Metabolism. ,vol. 87, pp. 364- 369 ,(2002) , 10.1210/JCEM.87.1.8180